Poland· PL-100028751

Herbapect

A expectorants product containing thymi herbae extractum + primulae radicis tinctura + sulfogaiacolum, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 8 of our 19 countries.

ATC R05CA

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedHerbapectATCR05CAREGISTER NO.PL-100028751PACKS LISTED5CHECKEDSeptember 27, 2026

Where it is registered

Thymi herbae extractum + primulae radicis tinctura + sulfogaiacolum is registered in 8 of 19 countries.

Countries holding a registration under ATC R05CA (expectorants), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Thymi herbae extractum + primulae radicis tinctura + sulfogaiacolum · ATC R05CA

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Thymi herbae extractum + Primulae radicis tinctura + Sulfogaiacolum
Manufacturer
Aflofarm Farmacja Polska Sp. z o.o.
Country
Poland (PL)
ATC code
R05CA
ATC class
Expectorants
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909990663620
  • gtin
    05909990663613
  • gtin
    05909990855735
  • gtin
    05909990962372
  • gtin
    05909990962389

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bf6a1078-d241-4c8a-ab25-61fd573a62d5
GET /v1/drugs/bf6a1078-d241-4c8a-ab25-61fd573a62d5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Syrop",
  "source": "urpl",
  "strength": "(498 mg + 348 mg + 87 mg)/5 ml",
  "packaging": "05909990663620 ¦ OTC ¦ 17454\n1 butelka 150 ml\n05909990663613 ¦ OTC ¦ 46735\n1 butelka 125 ml\n05909990855735 ¦ OTC ¦ 65450\n1 butelka 200 ml\n05909990962372 ¦ OTC ¦ 75131\n1 butelka 120 g\n05909990962389 ¦ OTC ¦ 75132\n1 butelka 240 g",
  "substance": "Thymi extractum fluidum (1:2) 8 g (ekstrahent etanol 30% (v/v), woda amoniakalna 25%, glicerol 95%) + Primulae radicis tinctura (1:5) 5,6 g (ekstrahent: etanol 70%) + Sulfogaiacolum 1.4 g",
  "common_name": "Thymi herbae extractum + Primulae radicis tinctura + Sulfogaiacolum",
  "pl_product_id": "100028751",
  "pozwolenie_nr": "06636",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about thymi herbae extractum + primulae radicis tinctura + sulfogaiacolum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.